Medtronic plc
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators,…
Medical - Devices
IE, Dublin [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Medtronic plc's gradings, price targets and earnings estimates.
Earnings
See the historical earnings and what wall street
analysts forecasted and
forecast for
future earnings.
Reported
Past Estimate Consensus
Future Estimate Consensus
FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
E | E | E | E | E | E | |||||||
2014 | - | 3.620 | - | 16,325 | - | 3,714 | - | 5,663 | - | 4,711 | - | 5,582 |
2015 | 2.4400 | 4.321 | 20,261 | 28,240 | 2,675 | 2,899 | 6,249 | 4,763 | 4,557 | 4,827 | 6,904 | 5,989 |
2016 | 2.5100 | 4.368 | 28,833 | 28,728 | 3,538 | 2,252 | 9,211 | 6,589 | 5,960 | 3,903 | 9,469 | 8,418 |
2017 | 2.9200 | 4.579 | 29,710 | 29,675 | 4,028 | 4,204 | 9,596 | 8,623 | 6,313 | 5,364 | 9,711 | 9,432 |
2018 | 2.2900 | 4.729 | 29,953 | 29,697 | 3,104 | 4,768 | 9,384 | 8,834 | 6,343 | 5,806 | 9,974 | 9,414 |
2019 | 3.4400 | 5.150 | 30,557 | 30,519 | 4,631 | 2,103 | 9,664 | 6,152 | 6,632 | 5,938 | 10,418 | 9,898 |
2020 | 3.5700 | 4.980 | 28,913 | 29,684 | 4,789 | 4,471 | 8,241 | 8,930 | 5,222 | 6,036 | 10,109 | 9,915 |
2021 | 2.6800 | 4.356 | 30,117 | 30,056 | 3,606 | 3,563 | 7,933 | 6,581 | 4,895 | 3,479 | 10,148 | 10,207 |
2022 | 3.7500 | 5.660 | 31,686 | 32,021 | 5,039 | 4,390 | 8,932 | 7,805 | 5,908 | 4,963 | 10,292 | 9,604 |
2023 | 2.8300 | 5.272 | 31,227 | 30,936 | 3,758 | 3,620 | 9,042 | 9,011 | 5,830 | 5,920 | 10,415 | 10,597 |
2024 | 2.7700 | 5.197 | 32,364 | 32,221 | 3,676 | 3,927 | 8,379 | 9,912 | 5,732 | 6,512 | 10,622 | 11,657 |
2025 | - | 5.454 | - | 33,625 | - | 7,114 | - | 9,272 | - | 6,344 | - | 11,251 |
2026 | - | 5.856 | - | 35,230 | - | 3.F12X/td> | - | 3.F121/td> | - | 3.F121 | - | 3.F121 |
2027 | - | 6.308 | - | 36,933 | - | 2.F13X/td> | - | 2.F131/td> | - | 2.F131 | - | 2.F131 |
2028 | - | 6.841 | - | 39,127 | - | 1.F14X/td> | - | 1.F141/td> | - | 1.F141 | - | 1.F141 |
2029 | - | 7.460 | - | 41,004 | - | 0.F15X/td> | - | 0.F151/td> | - | 0.F151 | - | 0.F151 |
Institutional Sentiment
Wall Street · Earnings · Institutional Sentiment
Morgan Stanley
1Y Ago:
Overweight
Prev. Grade
Overweight
Nov. 6, 2024
Overweight
JP Morgan Chase
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Citigroup
1Y Ago:
Equal-Weight
Prev. Grade
Equal-Weight
Nov. 6, 2024
Equal-Weight
Overall Consensus
Grading Consensus
Click to each, to see the gradePrice Target Consensus
-18.561% $15.04 · MISS
Nov. 6, 2024Price Then
$89.68
Price Target
$96.07
Price Now
$81.03